Table I.
Study population and procedural data (n = 44)
| Patients | Value | |
|---|---|---|
| Age [years] | 66.0 ±9.8 | |
| Male sex | 32 (72.7) | |
| Height [cm] | 169.8 ±8.0 | |
| Weight [kg] | 79.6 ±13.5 | |
| Body mass index [kg/m2] | 27.5 ±3.8 | |
| Arterial hypertension | 44 (100.0) | |
| Diabetes mellitus | 22 (50.0) | |
| Previous myocardial infarction | 23 (52.3) | |
| Previous PCI | 20 (45.5) | |
| Previous CABG | 0 (0.0) | |
| Peripheral arterial disease | 1 (2.3) | |
| Chronic obstructive pulmonary disease | 0 (0.0) | |
| Previous stroke/TIA | 0 (0.0) | |
| Hyperlipidemia | 50 (100.0) | |
| Smoking | 16 (36.4) | |
| Atrial fibrillation | 1 (2.3) | |
| Serum creatinine [µmol/l] | 88.8 ±16.4 | |
| LVEF, % | 52.6 ±8.5 | |
| LVEF < 40% | 1 (2.3) | |
| Heart rate [beats/min] | 71.9 ±9.5 | |
| Angina symptoms – CCS class: | ||
| I | 6 (13.6) | |
| II | 34 (77.3) | |
| III | 4 (9.1) | |
| Heart failure symptoms – NYHA class: | ||
| I | 38 (86.4) | |
| II | 4 (9.1) | |
| III | 1 (2.3) | |
| IV | 1 (2.3) | |
| Access: | ||
| Radial | 30 (68.2) | |
| Femoral | 14 (31.8) | |
| Number of assessed vessels | 3.0 (2.0–4.0) | |
Values presented as number (percentage), mean ± standard deviation or median (interquartile range). CABG – coronary artery bypass grafting, CCS – Canadian Cardiovascular Society, LVEF – left ventricle ejection fraction, NYHA – New York Heart Association, PCI – percutaneous coronary intervention, TIA – transient ischemic attack.